Evidence map›Paper›PMID 36614917›Full record

ArticleJournal of clinical medicine2022

Differential Effects of Patient Navigation across Latent Profiles of Barriers to Care among People Living with HIV and Comorbid Conditions.

Sharleen M Traynor, Renae D Schmidt, Lauren K Gooden, Tim Matheson, Louise Haynes, Allan Rodriguez, Michael Mugavero, Petra Jacobs, Raul Mandler, Carlos Del Rio and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 1 country.

Sharleen M TraynorClinical Trials Research Associate Program, Durham Technical Community College, Durham, NC 27703, USA.
Renae D SchmidtDepartment of Public Health Sciences, University of Miami Miller School of Medicine, 1120 Northwest 14th Street, Miami, FL 33136, USA.ORCID 0000-0002-0390-0712
Lauren K GoodenSociomedical Sciences Mailman School of Public Health, Columbia University, 722 West 168th Street, New York, NY 10032, USA.
Tim MathesonCenter on Substance Use and Health, San Francisco Department of Public Health, San Francisco, CA 94102, USA.
Louise HaynesDepartment of Psychiatry and Behavioral Science, Medical University of South Carolina, Charleston, SC 29425, USA.
Allan RodriguezDivision of Infectious Diseases, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Michael MugaveroDepartment of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, 1900 University Blvd # 229, Birmingham, AL 35233, USA.
Petra JacobsCenter for Clinical Trials Network, National Institute on Drug Abuse, Rockville, MD 20892, USA.
Raul MandlerDivision of Therapeutics and Medical Consequences, National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD 20892, USA.
Carlos Del RioDivision of Infectious Diseases, Emory University, Atlanta, GA 30322, USA.
Adam W CarricoDepartment of Public Health Sciences, University of Miami Miller School of Medicine, 1120 Northwest 14th Street, Miami, FL 33136, USA.
Viviana E HorigianDepartment of Public Health Sciences, University of Miami Miller School of Medicine, 1120 Northwest 14th Street, Miami, FL 33136, USA.ORCID 0000-0002-3578-0014
Lisa R MetschSociomedical Sciences Mailman School of Public Health, Columbia University, 722 West 168th Street, New York, NY 10032, USA.
Daniel J FeasterDepartment of Public Health Sciences, University of Miami Miller School of Medicine, 1120 Northwest 14th Street, Miami, FL 33136, USA.
University of Miami · USColumbia University · USDurham Technical Community College · USEmory University · USMedical University of South Carolina · USNational Institute on Drug Abuse · USNational Institutes of Health · USSan Francisco Department of Public Health · USUniversity of Alabama at Birmingham · US

Funding

FLORIDA NODE OF THE DRUG ABUSE CLINICAL TRIALS NETWORKU10DA013720 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI METSCH, LISA R, SZAPOCZNIK, JOSE · 2000 to 2015
$56.9M
The Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials NetworkUG1DA013720 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Daniel J Feaster, Viviana Elizabeth Horigian · 2015 to 2026
$50.6M
Training Program on HIV and Substance Use in the Criminal Justice SystemT32DA037801 · NIDA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Nabila El-Bassel, Lisa R Metsch · 2014 to 2026
$5.7M
NIDA NIH HHS T32 DA037801NIDA NIH HHS U10DA013720NIDA NIH HHS UG1 DA013720NIDA NIH HHS UG1DA013720
6 · The paper itself

Abstract

Engaging people living with HIV who report substance use (PLWH-SU) in care is essential to HIV medical management and prevention of new HIV infections. Factors associated with poor engagement in HIV care include a combination of syndemic psychosocial factors, mental and physical comorbidities, and structural barriers to healthcare utilization. Patient navigation (PN) is designed to reduce barriers to care, but its effectiveness among PLWH-SU remains unclear. We analyzed data from NIDA Clinical Trials Network's CTN-0049, a three-arm randomized controlled trial testing the effect of a 6-month PN with and without contingency management (CM), on engagement in HIV care and viral suppression among PLWH-SU (

Indexed as

barriers to careco-occurring disordersHIVpatient navigationsocial determinants of healthsubstance usesyndemic framework

Identifiers

PMID36614917
PMCPMC9820894
OpenAlexW4313245661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.